Haven’t heard anyone mention the near term catalyst MT quoted in the Q&A.
A readout on the OLE study in the quarterly … and every quarterly thereafter.
This will be post the SPP, and announcement of likely over subscription
Continued stellar results from the 10 patients on 10mg, nothing stopping a run on the SP IMO. Every positive readout on OLE each quarter will improve odds of success in Healey study…
What a setup … no waiting around for Healey study results for the rerate, and every positive OLE readout ramps up the pressure on BP to make an early move.
Ann: Investor Briefings & Webinar Notice, page-45
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 17.0¢ | $1.507K | 8.867K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 172806 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 469358 | 9 |
View Market Depth
| Last trade - 10.06am 18/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |